Literature DB >> 24372853

Actual 10-year survival following hepatectomy for hepatocellular carcinoma.

Bernardo Franssen1, Ghalib Jibara, Parissa Tabrizian, Myron E Schwartz, Sasan Roayaie.   

Abstract

OBJECTIVES: This study was conducted to compare 10-year survivors with patients who survived <10 years in a large Western series of patients submitted to hepatectomy for hepatocellular carcinoma (HCC).
METHODS: A retrospective review of a series of hepatic resections conducted in a referral centre for HCC between January 1987 and October 2002 was conducted.
RESULTS: A total of 176 patients were analysed. Twenty-eight patients survived ≥ 10 years (Group A) and were compared with the 148 patients who did not (Group B). Group A had smaller tumours (5.7 cm versus 8.2 cm; P = 0.001) and a lower incidence of microvascular invasion (18.5% versus 37.1%; P = 0.004). Recurrence did not differ significantly (Group A 18/28, 64.3% versus Group B 94/148, 63.5%). Median time to recurrence was longer in Group A (70 months versus 15 months; P < 0.0001), and more patients in Group A were able to undergo curative treatment for recurrence (88.8% versus 40.4%; P < 0.0001). Multivariate analysis showed that lack of vascular invasion (P = 0.020), absence of perioperative transfusion (P = 0.014), and recurrence at >2 years after primary resection (P = 0.045) were significantly associated with 10-year survival.
CONCLUSIONS: Ten-year survival after liver resection for HCC can be expected in approximately 15% of patients. Recurrence does not preclude longterm survival. Recurrence at >2 years after resection, absence of vascular invasion, and absence of perioperative transfusion are independently associated with 10-year survival.
© 2013 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2013        PMID: 24372853      PMCID: PMC4159456          DOI: 10.1111/hpb.12206

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  24 in total

Review 1.  Current strategy for staging and treatment: the BCLC update and future prospects.

Authors:  Alejandro Forner; María E Reig; Carlos Rodriguez de Lope; Jordi Bruix
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

2.  Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis.

Authors:  David Fuks; Safi Dokmak; Valérie Paradis; Momar Diouf; François Durand; Jacques Belghiti
Journal:  Hepatology       Date:  2012-01       Impact factor: 17.425

3.  An analysis of 412 cases of hepatocellular carcinoma at a Western center.

Authors:  Y Fong; R L Sun; W Jarnagin; L H Blumgart
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

4.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

5.  Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value.

Authors:  G L Grazi; G Ercolani; F Pierangeli; M Del Gaudio; M Cescon; A Cavallari; A Mazziotti
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

6.  Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis.

Authors:  S Ko; Y Nakajima; H Kanehiro; M Hisanaga; Y Aomatsu; T Kin; K Yagura; T Ohyama; K Nishio; K Ohashi; M Sho; T Yamada; H Nakano
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

Review 7.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

8.  A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma.

Authors:  Sasan Roayaie; Iris N Blume; Swan N Thung; Maria Guido; Maria-Isabel Fiel; Spiros Hiotis; Daniel M Labow; Josep M Llovet; Myron E Schwartz
Journal:  Gastroenterology       Date:  2009-06-12       Impact factor: 22.682

9.  Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.

Authors:  Steven C Katz; Jinru Shia; Kui Hin Liau; Mithat Gonen; Leyo Ruo; William R Jarnagin; Yuman Fong; Michael I D'Angelica; Leslie H Blumgart; Ronald P Dematteo
Journal:  Ann Surg       Date:  2009-04       Impact factor: 12.969

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  16 in total

1.  Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma.

Authors:  Jian Zheng; Deborah Kuk; Mithat Gönen; Vinod P Balachandran; T Peter Kingham; Peter J Allen; Michael I D'Angelica; William R Jarnagin; Ronald P DeMatteo
Journal:  Ann Surg Oncol       Date:  2016-12-05       Impact factor: 5.344

2.  Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.

Authors:  Georg Lurje; Jan Bednarsch; Zoltan Czigany; Iakovos Amygdalos; Franziska Meister; Wenzel Schöning; Tom Florian Ulmer; Martin Foerster; Cornelis Dejong; Ulf Peter Neumann
Journal:  Langenbecks Arch Surg       Date:  2018-09-28       Impact factor: 3.445

3.  Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection.

Authors:  Zhangjun Cheng; Pinghua Yang; Shuping Qu; Jiahua Zhou; Jue Yang; Xinwei Yang; Yong Xia; Jun Li; Kui Wang; Zhenlin Yan; Dong Wu; Baohua Zhang; Norbert Hüser; Feng Shen
Journal:  HPB (Oxford)       Date:  2014-11-24       Impact factor: 3.647

Review 4.  Hepatocellular carcinoma.

Authors:  Josep M Llovet; Robin Kate Kelley; Augusto Villanueva; Amit G Singal; Eli Pikarsky; Sasan Roayaie; Riccardo Lencioni; Kazuhiko Koike; Jessica Zucman-Rossi; Richard S Finn
Journal:  Nat Rev Dis Primers       Date:  2021-01-21       Impact factor: 52.329

5.  Efficacy and Safety of Apatinib in Advanced Hepatocellular Carcinoma: A Multicenter Real World Retrospective Study.

Authors:  Zhuangzhuang Zheng; Zijing Liu; Haifeng Zhang; Xiao Guo; Xiaojing Jia; Jianfeng Wang; Lingbin Meng; Ying Xin; Xin Jiang
Journal:  Front Pharmacol       Date:  2022-05-17       Impact factor: 5.988

6.  Identification of Actual 10-Year Survival After Hepatectomy of HBV-Related Hepatocellular Carcinoma: a Multicenter Study.

Authors:  Zhen-Li Li; Wen-Tao Yan; Jin Zhang; Yi-Jun Zhao; Wan Yee Lau; Xian-Hai Mao; Yong-Yi Zeng; Ya-Hao Zhou; Wei-Min Gu; Hong Wang; Ting-Hao Chen; Jun Han; Hao Xing; Han Wu; Chao Li; Ming-Da Wang; Meng-Chao Wu; Feng Shen; Tian Yang
Journal:  J Gastrointest Surg       Date:  2018-10-17       Impact factor: 3.452

7.  Long-Term Prognostic Factors after Hepatic Resection for Hepatitis C Virus-Related Hepatocellular Carcinoma, with a Special Reference to Viral Status.

Authors:  Masaki Koda; Shogo Tanaka; Shigekazu Takemura; Hiroji Shinkawa; Masahiko Kinoshita; Genya Hamano; Tokuji Ito; Norifumi Kawada; Toshihiko Shibata; Shoji Kubo
Journal:  Liver Cancer       Date:  2018-03-13       Impact factor: 11.740

8.  Identification of recurrence-related serum microRNAs in hepatocellular carcinoma following hepatectomy.

Authors:  Liming Wang; Mei Liu; Hongxia Zhu; Weiqi Rong; Fan Wu; Songlin An; Faqiang Liu; Li Feng; Jianxiong Wu; Ningzhi Xu
Journal:  Cancer Biol Ther       Date:  2015-07-15       Impact factor: 4.742

9.  Laparoscopic detection and resection of occult liver tumors of multiple cancer types using real-time near-infrared fluorescence guidance.

Authors:  Leonora S F Boogerd; Henricus J M Handgraaf; Hwai-Ding Lam; Volkert A L Huurman; Arantza Farina-Sarasqueta; John V Frangioni; Cornelis J H van de Velde; Andries E Braat; Alexander L Vahrmeijer
Journal:  Surg Endosc       Date:  2016-06-29       Impact factor: 4.584

10.  Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments.

Authors:  Fanyu Meng; Haoyun Zhang; Haiwen Peng; Shichun Lu
Journal:  Biomed Res Int       Date:  2021-03-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.